DRUG · Unmapped registry intervention
Riociguat (Adempas, BAY63-2521)
Find medicine records ·
Find other trials using this name
Clinical trial
Riociguat in Children With Pulmonary Arterial Hypertension (PAH)
NCT02562235
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedRiociguat in Children With Pulmonary Arterial Hypertension (PAH)
Design: INTERVENTIONAL · Status: ACTIVE NOT RECRUITING · Phase: PHASE3
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Hypertension, Pulmonaryunresolved
Interventions
Sponsors & collaborators
Bayerlead sponsor
Merck Sharp & Dohme LLCcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02562235 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.